Skip to main content

Table 4 Adjusted ORs of the association of metabolic health status with high-risk baPWV in 12-year follow-ups

From: Effect of metabolically healthy obesity on the development of arterial stiffness: a prospective cohort study

BMI and metabolic status No. with high baPWV (%) Unadjusted OR (95%CI) Model 1 OR (95%CI) Model 2 OR (95%CI) Model 3 OR (95%CI)
MHNO 16 (15.2) 1.00 1.00 1.00 1.00
MUNO 22 (43.1) 4.22a (1.96–9.10) 5.21a (2.26–12.01) 3.54a(1.42–8.82) 2.88a(1.09–7.59)
MHO 7 (30.4) 2.43 (0.86–6.85) 2.44 (0.79–7.52) 0.40 (0.08–1.92) 1.55 (0.30–8.06)
MUO 10 (43.5) 4.28a (1.60–11.42) 3.32a (1.18–9.32) 2.10 (0.68–6.54) 4.01 (0.75–21.56)
  1. Odds ratio, OR; confidence interval, CI; baPWV, brachial-ankle pulse wave velocity; BMI, body mass index; MHNO, metabolically healthy nonobesity, MUNO, metabolically unhealthy nonobesity; MHO, metabolically healthy obesity; MUO, metabolically unhealthy obesity
  2. MHNO was the reference group
  3. Model 1: adjusted for age and sex;
  4. Model 2: based on model 1 and history of hypertension, history of diabetes mellitus, history of hyperlipemia, smoke habits and alcohol consumption
  5. Model 3: based on model 2 and further adjusted for BMI, fasting plasma glucose, total cholesterol, triglycerides, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, urinary albumin-to-creatinine ratio and estimated glomerular filtration rate in 2017
  6. asignificant values